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Abstract 
Background  
The PREP2 algorithm combines clinical and neurophysiological measures to predict upper-
limb (UL) motor outcomes 3 months post-stroke, using four prediction categories based on 
Action Research Arm Test (ARAT) scores. The algorithm was accurate at 3 months for 75% 
of participants in a previous validation study. 
Objective 
This study aimed to evaluate whether PREP2 predictions made at baseline are correct 2 
years post-stroke. We also assessed whether patients’ UL performance remained stable, 
improved or worsened between 3 months and 2 years after stroke. 
Methods 
This is a follow-up study of 192 participants recruited and assessed in the original PREP2 
validation study. Participants who completed assessments 3 months post-stroke (n = 157) 
were invited to complete follow-up assessments at 2 years post-stroke for the present study. 
UL outcomes were assessed with the ARAT, upper extremity Fugl-Meyer scale (FM-UE), 
and Motor Activity Log (MAL). 
Results 
Eighty-six participants completed 2-year follow-up assessments in this study. PREP2 
predictions made at baseline were correct for 69/86 (80%) of participants 2 years post-
stroke, and PREP2 UL outcome category was stable between 3 months and 2 years post-
stroke for 71/86 (83%). There was no difference in age, stroke severity or comorbidities 
between patients whose category remained stable, improved or deteriorated.  
Conclusions 
PREP2 algorithm predictions made within days of stroke are correct at both 3 months and 2 
years post-stroke for most patients. Further investigation may be useful to identify which 
patients are likely to improve, remain stable or deteriorate between 3 months and 2 years.  
Keywords: Upper limb; Motor; Prognosis; Outcome; Biomarkers; Stroke; Rehabilitation   
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Introduction 
Recovery of upper-limb (UL) function after stroke is important for regaining independence in 
activities of daily living.1 Early prediction of UL outcome may increase rehabilitation 
efficiency by tailoring therapy for individual patients.2 However, making accurate predictions 
for individual patients based on clinical measures alone can be difficult.3 
 
The PREP2 algorithm combines clinical and neurophysiological measures within a few days 
of stroke to make predictions for UL functional outcomes at 3 months post-stroke 
(www.presto.auckland.ac.nz).4 Patients are predicted to achieve one of four functional UL 
outcome categories: Excellent, Good, Limited or Poor. These UL functional outcome 
categories are based on ranges of scores on the Action Research Arm test (ARAT), which 
were previously established through hypothesis free cluster analysis5 and subsequently 
refined (Table 1).4 Information that can be offered to patients in each predicted outcome 
category is provided in Table 1. This includes the expected level of UL function by 3 months 
post-stroke, and a suggested rehabilitation focus.  
 
The PREP2 algorithm starts by grading paretic UL shoulder abduction and finger extension 
(SAFE) strength at day 3 post-stroke using the Medical Research Council grades (Figure 1). 
If the sum of these grades is ≥ 5/10, the patient’s age (< 80 or ≥ 80) is taken into account to 
predict either an Excellent or Good UL functional outcome at 3 months. For patients with a 
SAFE score <5, ipsilesional corticospinal system function is evaluated with transcranial 
magnetic stimulation (TMS). Patients with motor evoked potentials (MEP+) in the first dorsal 
interosseus (FDI) or extensor carpi radialis (ECR) muscles of the paretic UL are predicted to 
achieve a Good UL functional outcome, regardless of the initial motor impairment. Patients 
without MEPs (MEP-) are predicted to achieve a Limited or Poor functional UL outcome, 
depending on overall stroke severity measured at day 3 post-stroke with the National 
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Institute of Health Stroke Scale (NIHSS). At 3 months post-stroke PREP2 predictions are 
correct for 75% of patients, with predictions too optimistic for most of the remaining 25%.4 
 
Most motor recovery after stroke occurs within the first 3 months.6-12 However, a plateau in 
motor performance might not occur until 5 to 6 months post-stroke for some patients with 
more severe initial impairment.13,14  To the best of our knowledge, no longitudinal studies 
have tracked UL performance from early after stroke for more than 6 months. This means 
little is known about what happens to UL impairment, function, and use once a patient 
reaches plateau and moves into the early chronic phase of stroke. Learned non-use may 
contribute to deterioration in UL motor function from the peak motor performance achieved 
at plateau, particularly for patients with more severe UL impairment.14,15 This could make it 
difficult to discern whether the benefits of UL therapy reported in studies with patients at the 
chronic stage are due to improvements over and above participants’ previous maximal 
function, or due to participants being boosted back up to their previous best after 
deterioration since the sub-acute stage.  
 
The aim of this study was to determine whether PREP2 predictions made within a few days 
post-stroke were correct 2 years after stroke, and determine whether UL performance 
improves, deteriorates or remains stable between 3 months and 2 years after stroke. We 
hypothesised that PREP2 predictions made at baseline would be correct at 2 years post-
stroke, and PREP2 outcome category and UL motor performance would remain stable 
between 3 months and 2 years after stroke.  
 
Methods 
This is a follow-up study of the 192 patients recruited within 3 days of stroke to participate in 
the PREP2 algorithm validation study, which was previously reported.2 Patients were eligible 
for participation in the PREP2 validation study if they were aged at least 18 years, and had 
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experienced an ischemic stroke or intracerebral hemorrhage producing unilateral UL 
weakness within the previous 72 hours. Previous stroke and acute reperfusion therapies 
were allowed. Patients were excluded if they had cerebellar stroke, cognitive or 
communication impairments precluding informed consent, or if they lived out of the study 
area precluding follow-up. The PREP2 algorithm (Figure 1) was used to predict UL functional 
outcome within days of stroke for all participants in the validation study.4  
 
Of the original 192 participants in the PREP2 validation study, 157 (82%) completed follow-
up assessments at 3 months post-stroke. At 2 years post stroke, attempts were made to 
contact all participants who had completed 3 month assessments in the PREP2 validation 
study (n = 157) to determine eligibility for participation in the present 2 year follow-up study. 
All 157 participants were considered eligible unless they had moved out of the study area 
(not available for in person assessments), they were unable to be contacted, or their medical 
status, cognition or communication had declined to the point that they were no longer able to 
provide informed consent or were too unwell to participate. The 2 year time point was 
chosen to maximise the time since stroke while minimising the expected natural attrition over 
time as patients experience medical deterioration or death.16 The study was approved by the 
regional ethics committee and written informed consent was obtained from each participant. 
 
Follow-up assessments at 2 years post-stroke were completed by trained clinical assessors 
who were blinded to the participants’ original PREP2 prediction. The assessments included: 
Action Research Arm Test (ARAT) to determine PREP2 outcome category at 2 years; upper 
extremity Fugl-Meyer Assessment (FM-UE) to measure motor impairment; and the Motor 
Activity Log (MAL) for self-reported use of the paretic UL. Baseline clinical and demographic 
data, baseline PREP2 prediction, 3 month PREP2 outcome category, and 3 month FM-UE, 
ARAT and MAL scores for each participant were retrieved from the PREP2 validation study 
dataset. 
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Non-parametric tests were used for analyses due to the non-normal distributions of data. 
Pearson Chi-Square tests were used to compare categorical baseline characteristics of 
participants included in this study (n = 86) with those who were not available for follow-up at 
2 years (n = 71). The percentage of patients in this follow-up study who achieved their 
predicted UL outcome at 2 years was calculated. The percentage of patients that changed 
PREP2 outcome category between 3 months and 2 years post-stroke was also calculated 
separately for patients whose category improved or worsened. Clinical scores (ARAT, FM-
UE, MAL) were compared between 3 months and 2 years post-stroke using related-samples 
Wilcoxon signed rank tests. Differences of 6 points in the FM-UE and ARAT scores were 
considered clinically meaningful.17,18 All tests were two-sided with alpha = 0.05 and are 
reported with 95% confidence intervals.  
 
Results 
Of the 157 PREP2 validation study patients who completed a 3 month post-stroke 
assessment, 86 participated in the present follow-up study at 2 years post-stroke (33 (38%) 
women, mean (SD) age 72 (13) y) (Figure 2, Table 2). These 86 participants had a lower 
median age, a lower incidence of atrial fibrillation, fewer comorbidities, and a lower 
proportion of women compared to the 71 patients who were not available for follow-up at 2 
years (Table 2). The reasons for being unavailable for follow up assessment at 2 years are 
reported in Figure 2: deceased (19), unable to be contacted (19), medically unwell (8), 
cognitive deterioration (3), moved out of the study area (9), and declined to participate (13). 
 
PREP2 predictions made at baseline were correct for 69/86 participants (80%) 2 years post-
stroke (Table 3). Of the remaining 17 participants, PREP2 category was better than 
predicted for 9 (11%) and worse than predicted for 8 (9%) participants at 2 years post-
stroke.  
 
  PREP2 predictions at 2 years 
7 
 
Most participants (71/86, 83%) remained in the same PREP2 UL outcome category between 
3 months and 2 years post-stroke. Of the 15 participants who changed category, 10 
improved, 5 deteriorated, and all were predicted to achieve either a Good or Excellent UL 
outcome (Figure 3). Six of the 10 participants who improved had not achieved their predicted 
Excellent outcome category by 3 months, but achieved it by 2 years. Two of the 10 
participants who improved had achieved their predicted Good outcome by 3 months, but 
exceeded their prediction, achieving an Excellent UL outcome by 2 years.  The remaining 
two participants who improved had been predicted to achieve a Good outcome by 3 months, 
but had only achieved a Limited outcome by this time. Between 3 months and 2 years, one 
of these participants improved to achieve their predicted Good outcome, and the other 
exceeded their predicted Good outcome to achieve an Excellent outcome. None of the 
participants predicted to achieve a Limited or Poor outcome changed categories between 3 
months and 2 years post-stroke. There were no differences in age, stroke severity, or 
comorbidities between participants whose UL outcome category remained stable, improved 
or worsened (all p > 0.1).  
 
ARAT, FM-UE, and MAL scores could change between 3 months and 2 years without 
resulting in a change in PREP2 outcome category. Therefore, the differences in these UL 
scores between 3 months and 2 years were also examined. At the group level, the median 
difference between ARAT scores at 3 months and 2 years was 1 point (95% CI 0 – 1.5, p = 
0.012), and for FM-UE scores was 1.5 points (95% CI 0.5 – 2.5, p = 0.005). These 
differences are statistically significant but not clinically meaningful6, 7 (Table 3). However, 
some individual participants exhibited clinically meaningful increases and decreases in 
ARAT (n = 13, 15%) and FM-UE (n = 26, 30%) scores (Table 3), without necessarily 
changing outcome category. Of the 18 (21%) participants who increased FM scores by 6 
points or more, 6 participants also exhibited clinically meaningful increases in ARAT score, 
and 5 of these improved PREP2 outcome category. Four of the 8 participants who 
decreased FM score also decreased ARAT score and dropped to a lower PREP2 UL 
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outcome category. Three participants (3%) meaningfully improved ARAT score without a 
corresponding increase in FM score. The median difference between MAL scores at 3 
months and 2 years was 0.1 (-0.03 – 0.4), which was neither statistically nor clinically 
significant. 
  
Discussion 
PREP2 algorithm predictions about UL functional outcome made within days of stroke are 
correct for 80% of patients at 2 years post-stroke. Most participants (83%) remained in the 
same PREP2 category between 3 months and 2 years, and median scores for motor 
function (ARAT), motor impairment (FM-UE), and use of the paretic hand and arm (MAL) did 
not meaningfully change between these time points. These results indicate that functional 
limitations seen in patients at the chronic stage are predictable and likely to have been fairly 
stable since 3 months post-stroke. Of the ten participants whose UL outcome category 
improved between 3 months and 2 years, only three exceeded their original prediction, while 
the remaining seven took longer than 3 months to achieve their original predicted UL 
function, achieving this by 2 years post-stroke.  Five participants deteriorated to a lower 
category between 3 months and 2 years. None of the participants predicted to achieve a 
Limited or Poor outcome changed categories between 3 months and 2 years post-stroke. 
There was no difference in age, stroke severity or comorbidities between those whose 
category remained stable, improved or deteriorated. Further investigation would be useful to 
identify factors that predict which patients take longer than 3 months to achieve their 
predicted UL function and which patients are at risk of deteriorating after 3 months. 
 
While median ARAT and FM-UE scores did not meaningfully change between 3 months and 
2 years after stroke for this group of participants, some individuals did exhibit a meaningful 
increase or decrease in these scores. However, only a third of the 18 participants who 
experienced a meaningful increase in FM-UE scores also experienced a meaningful 
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increase in UL hand and arm function (ARAT score), and only half of those who decreased 
FM scores (n=8) also decreased ARAT score. Despite a clinically meaningful change in UL 
function on the ARAT score for these participants, self-reported use of the UL did not 
change. This reflects the high threshold required for patients to translate changes in UL 
impairment into UL function and use of the UL in daily life. 21 
 
Spontaneous biological recovery processes drive improvements in motor control and 
impairment during the initial weeks after stroke with most motor recovery occurring within the 
first 3 months post-stroke.6-11 However studies at the chronic stage also report improvements 
in UL function after therapeutic interventions. The findings of this study shed some light on 
whether these improvements at the chronic stage are over and above previous best 
performance or whether the benefit from UL therapy at the chronic stage is due to re-
conditioning, or boosting the patients back up to previous best function.  Although ARAT 
score meaningfully increased for 9 (10%) and decreased for 4 (5%) participants between 3 
months and 2 years post-stroke, overall UL performance (UL impairment, function and self-
reported use) remained fairly stable during this time for the majority of participants. This 
stability in UL performance between 3 months and 2 years post-stroke suggests that 
improvements at the group level, reported after an intervention at the chronic stage, are 
likely to be true improvements over and above previous performance.  At the chronic stage, 
improvements in motor performance may be achieved by learning to compensate for 
residual impairments, as motor learning is unimpaired after stroke.19,20  
  
Of the 157 PREP2 validation study participants assessed at 3 months, only 86 (55%) were 
available to participate in this follow-up study 2 years after stroke. These participants were 
younger, had a lower proportion of women, and had fewer co-morbidities, compared to those 
who were unavailable. Stroke type, location and severity did not distinguish between patients 
available for follow-up and those who were unavailable. The unavailability of nearly half of 
the PREP2 validation study participants limited the sample size for this follow-up study. 
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However, this was largely unavoidable, as most were unavailable due to illness, death, or 
moving out of the study area. This attrition rate is similar to other longitudinal studies post-
stroke.16 Other limitations of this study include a lack of measures between 3 months and 2 
years post-stroke, and no record of any UL rehabilitation undertaken in this time.  
 
In conclusion, using the PREP2 algorithm, it is possible to predict UL functional outcomes 
within a few days of stroke, and these predictions are correct for most patients at both 3 
months and 2 years. Most UL motor recovery occurs within the first 3 months after stroke, 
therefore 3 months is an appropriate time point for UL predictions. Further investigation may 
be useful to improve the overall accuracy of the algorithm and identify which patients are 
likely to improve, remain stable or deteriorate between 3 months and 2 years. 
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Figure legends 
 
Figure 1. The PREP2 algorithm. SAFE = Shoulder Abduction, Finger Extension score, which 
is the sum of the Medical Research Council grades for each of these movements, out of 5, 
for a total SAFE score out of 10. MEP+ = Motor Evoked Potentials can be elicited from the 
paretic extensor carpi radialis (ECR) and/or first dorsal interosseous (FDI) muscles of the 
paretic UL using transcranial magnetic stimulation. NIHSS = National Institutes of Health 
Stroke Scale. The algorithm predicts one of four possible upper limb functional outcomes at 
3 months post-stroke. Each prediction category is associated with rehabilitation goals that 
can be used to tailor upper limb therapy.2 The coloured dots represent, proportionally, 
PREP2 algorithm accuracy. The dots are colour coded based on the outcome category 
actually achieved 3 months post-stroke (Green = Excellent, Blue = Good, Orange = Limited, 
Red = Poor).  
 
Figure 2: Study flowchart.  
 
Figure 3: Fifteen participants changed PREP2 category between 3 months and 2 years, 
based on Action Research Arm Test (ARAT) score (max = 57). The 71 participants who did 
not change category are not depicted. Each dot represents a participant and is colour coded 
based on their original PREP2 prediction (Green = Excellent, Blue = Good). The coloured 
zone indicates the PREP2 outcome category actually achieved. Dots that do not match the 
colour of their zone indicates the participant either under or over-achieved their prediction at 
that time point. For example, six participants predicted to achieve an Excellent UL outcome 
(green dot) by 3 months only achieved a Good UL outcome (blue zone) at this time point. 
They improved to achieve their Excellent UL outcome by 2 years.  
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Table 1. PREP2 prediction category description and suggested rehabilitation focus 
Predicted 
Outcome 
ARAT score 
(out of 57) 
Category description Rehabilitation focus 
Excellent 50 - 57 
Potential to use the hand and arm 
fairly normally for most activities of 
daily living within three months 
Promote normal function of the 
affected hand and arm by 
improving strength, 
coordination, and fine motor 
control. Minimise compensation 
with the other hand and arm, 
and the trunk. 
Good 34 - 48 
Potential to be using the affected 
hand and arm for most activities of 
daily living within three months, 
though with some weakness, 
slowness, or clumsiness 
Promote normal function of the 
affected hand and arm by 
improving strength, 
coordination. Minimise 
compensation with the other 
hand and arm, and the trunk. 
Limited 13 - 31 
Potential to regain some 
movement in the affected hand 
and arm within three months, but 
daily activities are likely to require 
significant modification. Unlikely to 
regain dextrous hand function. 
Improve strength and active 
range of motion. Promote 
adaptation in daily activities, 
incorporating the affected upper 
limb wherever safely possible. 
Poor 0 - 9 
Unlikely to regain useful hand and 
arm function within three months. 
May be able to use the affected 
hand and arm as a stabiliser in 
bimanual tasks. 
Prevent secondary 
complications such as pain, 
spasticity and shoulder 
instability. Reduce disability by 
learning to complete daily 
activities with the stronger hand 
and arm. 
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 Table 2. Baseline data obtained within 7 days post-stroke. 
 
 
 
 Full sample  
at 3 m  
(n = 157) 
Not assessed 
at 2 y 
(n = 71) 
Assessed  
at 2 y 
(n = 86) 
p-value 
Demographic characteristics     
Age, y     
 Median (range) 74 (18 - 98) 78 (18 - 98) 72 (38 - 93) 0.024 
Sex     
 Female 73 (46%) 40 (56%) 33 (38%) 0.025 
Stroke risk factors     
 Smoker 14 (9%) 8 (11%) 6 (7%) 0.62 
 Ex-smoker 28 (18%) 13 (18%) 15 (17%) 0.62 
 Diabetes mellitus 36 (23%) 19 (27%) 17 (20%) 0.30 
 Hypertension 101 (64%) 47 (66%) 54 (63%) 0.66 
 Dyslipidemia 49 (31%) 23 (32%) 26 (30%) 0.77 
 Atrial fibrillation 40 (25%) 24 (34%) 16 (19%) 0.03 
 Previous cardiac history 49 (31%) 26 (37%) 23 (27%) 0.18 
Comorbidities     0.001 
 Low (Charlson < 2) 109 (69%) 40 (56%) 69 (80%)  
 High (Charlson ≥ 2) 48 (31%) 31 (44%) 17 (20%)  
Stroke characteristics     
First stroke 131 (83%) 56 (79%) 75 (87%) 0.16 
Stroke type    0.65 
  Total anterior circulation infarct 11 (7%) 5 (7%) 6 (7%)  
  Partial anterior circulation infarct 65 (41%) 34 (48%) 31 (36%)  
  Lacunar infarct 51 (32%) 20 (28%) 31 (36%)  
  Posterior circulation infarct 
  (excluding cerebellar) 
9 (6%) 4 (6%) 5 (6%)  
  Intracerebral hemorrhage 21 (13%) 8 (11%) 13 (15%)  
Hemisphere     
 Right 77 (49%) 39 (55%) 38 (44%) 0.18 
Thrombolysis     
 Yes 17 (11%) 8 (11%) 9 (11%)  0.87 
Clot retrieval     
 Yes 2 (1%) 1 (1%) 1 (1%) 1.00 
Stroke severity     
 NIHSS median (range) 4 (0 - 19) 4 (0 - 17) 4 (0 - 19) 0.74 
Motor impairment     
 FM-UE median (range) 52 (2 - 65) 49 (4 - 65) 52 (2 - 65) 0.87 
    SAFE ≥ 5 111 (71%) 48 (68%) 63 (73%) 0.44 
    SAFE < 5 46 (29%) 23 (32%) 23 (27%)  
MEPs present 134 (85%) 57 (80%) 77 (90%) 0.10 
PREP2 prediction      0.32 
 Excellent 98 (63%) 40 (56%) 58 (67%)  
 Good 38 (24%) 18 (26%) 20 (23%)  
 Limited 4 (3%) 3 (4%) 1 (1%)  
 Poor 17(10%) 10 (14%) 7 (8%)  
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Table 3. Follow-up assessments for participants who completed both 3 month and 2 year 
assessments post-stroke. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3m 
(n = 86) 
2y 
(n = 86) 
p-value 
PREP2 category      
 Excellent 56 (65%) 60 (70%)  
 Good 20 (23%) 18 (21%)  
 Limited 2 (2%) 0 (0%)  
 Poor 8 (9%) 8 (9%)  
PREP2 category correctly predicted (%) 69 (80%) 69 (80%)  
PREP2 category worse than predicted (%) 11 (13%) 8 (9%)  
PREP2 category better than predicted (%) 6 (7%) 9 (11%)  
ARAT     
 median (range) 54 (0 - 57) 56 (0 - 57)  
 median difference (95% CI)  1 (0.0 - 1.5) 0.012 
 ARAT score improved ≥ 6 points (%)  9 (10%)  
 ARAT score deteriorated ≥ 6 points (%)  4 (5%)  
FM-UE    
 median (range) 60 (7 - 66) 62.5 (4 - 66)  
 median difference (95% CI)  1.5 (0.5 - 2.5) 0.005 
 FM-UE score improved ≥ 6 points (%)  18 (21%)  
 FM-UE score deteriorated ≥ 6 points (%)  8 (9%)  
Motor Activity Log    
 median (range) 8.1 (0–10) 8.6 (0 - 10)  
 median difference (95% CI)  0.1 (-0.03 - 0.4) 0.2 
